Bio-Rad Posts 2 Percent Gain in Q2 Revenues | GenomeWeb

This article has been updated to include comments made during Bio-Rad's earnings call.

NEW YORK (GenomeWeb) – Bio-Rad Laboratories reported after the close of the market Wednesday that its second quarter revenues climbed 2 percent year over year as its profit was hit by expenses.

The Hercules, California-based life sciences tools and diagnostics firm reported total revenues of $516.8 million for the three months ended June 30 compared to $506.1 million for Q2 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.